This January, Germany’s largest vaccine maker BioNTech announced that it had agreed to acquire Tunisian-born and London-headquartered AI startup InstaDeep for up to £562 million, including a performance-tied £200 million tranche investment. InstaDeep’s deal — subject to regulatory approval and expected to close in the first half of this year — is quite intriguing…
Read More
About The Author
